Preliminary results from the skin cancer cohorts from an ongoing multi-cohort phase 2 clinical trial of RP1 combined with nivolumab (IGNYTE)Ari M. Vanderwalde,Mohammed M. Milhem,Tawnya L. Bowles,Joseph J. Sacco,Jiaxin Niu,Katy K. Tsai,Jason A. Chesney,Bartosz Chmielowski,Adel Samson,Terence D. Rhodes,Praveen K. Bommareddy,Lavita Menezes,Syed Raza, Shui He,Robert S. Coffin,Kevin Harrington,Mark R. MiddletonJOURNAL OF TRANSLATIONAL MEDICINE（2022）引用 0|浏览21暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
